The association of antihypertensive agents with MRI white matter findings and with modified mini-mental state examination in older adults

Journal of the American Geriatrics Society

Volumn 45, Issue 12, 1997, Pages 1423-1433

  Heckbert, Susan R ^a,g   Longstreth Jr , W T ^a   Psaty, Bruce M ^a   Murros, Kari E ^b,c   Smith, Nicholas L ^a   Newman, Anne B ^d   Williamson, Jeff D ^e   Bernick, Charles ^f   Furberg, Curt D ^c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g Cardiovasc Hlth Stud Coord Ctr   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT;

AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RACE DIFFERENCE; SEX DIFFERENCE; WHITE MATTER;

EID: 1842332728     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1997.tb03191.x     Document Type: Article

References (41)

1. Longstreth WT Jr, Manolio TA, Arnold A et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: The Cardiovascular Health Study. Stroke 1996;27:1274-1282.
2. Manolio TA, Kronmal RA, Burke GL et al. Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study. Stroke 1994;25:318-327.
3. Lindgren A, Roijer A, Rudling O et al. Cerebral lesions on magnetic resonance imaging, heart disease, and vascular risk factors in subjects without stroke. A population-based study. Stroke 1994;25:929-934.
4. Breteler MM, van Swieten JC, Bots ML et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: The Rotterdam Study. Neurology 1994;44:1246-1252.
5. Awad IA, Spetzler RF, Hodak JA et al. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors. Stroke 1986;17:1084-1089.
6. Fazekas F, Niederkorn K, Schmidt R et al. White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. Stroke 1988;19:1285-1288.
7. Kobayashi S, Okada K, Yamashita K. Incidence of silent lacunar lesion in normal adults and its relation to cerebral blood flow and risk factors. Stroke 1991;22:1379-1383.
8. Liao D, Cooper L, Cai J et al. Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Stroke 1996;27:2262-2270.
9. Oppenheimer SM, Bryan RN, Conturo TE et al. Proton magnetic resonance spectroscopy and gadolinium-DTPA perfusion imaging of asymptomatic MRI white matter lesions. Magn Reson Med 1995;33:61-68.
10. Boone KB, Miller BL, Lesser IM et al. Neuropsychological correlates of white-matter lesions in healthy elderly subjects. A threshold effect. Arch Neurol 1992;49:549-554.
11. Schmidt R, Fazekas F, Koch M et al. Magnetic resonance imaging cerebral abnormalities and neuropsychologic test performance in elderly hypertensive subjects. Arch Neurol 1995;52:905-910.
12. Fukuda H, Kitani M. Differences between treated and untreated hypertensive subjects in the extent of periventricular hyperintensities observed on brain MRI. Stroke 1995;26:1593-1597.
13. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: A review. Stroke 1997;28:652-659.
14. Fried LP, Borhani NO, Enright P et al. The Cardiovascular Health Study: Design and rationale. Ann Epidemiol 1991;1:263-276.
15. Tell GS, Fried LP, Hermanson B et al.. Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. Ann Epidemiol 1993;3:358-366.
16. Psaty BM, Kuller LH, Bild D et al. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol 1995;5:270-277.
17. Teng EL, Shui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987;48:314-8.
18. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-193.
19. O'Leary DH, Polak JF, Wolfson SKJ et al. Use of sonography to evaluate carotid atherosclerosis in the elderly. Stroke 1991;22:1155-1163.
20. Bryan RN, Manolio TA, Schertz LD et al. A method for using MR to evaluate the effects of cardiovascular disease on the brain: the Cardiovascular Health Study. Am J Neuroradiol 1994;15:1625-1633.
21. Psaty BM, Lee M, Savage PJ et al. Assessing the use of medications in the elderly: Methods and initial experience in the Cardiovascular Health Study. J Clin Epidemiol 1992;45:683-692.
22. Physicians' Desk Reference. Montvale, NJ: Medical Economics Data Production Company, 1996.
23. Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariable methods, 2nd Ed. Boston: PWS-Kent Pub. Co., 1988.
24. Norusis MJ, SPSS Inc. SPSS Advanced Statistics 6.1. Chicago, IL: SPSS, Inc., 1994.
25. Román GC. From UBOs to Binswanger's disease. Impact of magnetic resonance imaging on vascular dementia research. Stroke 1996;27:1269-1273.
26. Pantoni L, Garcia JH. Cerebral ischemia and cognitive impairment in the elderly: Facts. Res Gerontol 1996;(Suppl: Stroke):171-182.
27. Neaton JD, Grimm RH, Jr., Prineas RJ et al. Treatment of Mild Hypertension Study: Final results. JAMA 1993;270:713-724.
28. Ruzicka M, Leenen FHH. Relevance of intermittent increases in sympathetic activity for adverse outcome on short-acting calcium antagonists. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. New York: Raven Press, 1995, pp 2815-2824.
29. Baloh RW, Vinters HV. White matter lesions and disequilibrium in older people. II. Clinicopathologic correlation. Arch Neurol 1995;52:975-981.
30. Pantoni L, Inzitari D, Pracucci G et al. Cerebrospinal fluid proteins in patients with leucoaraiosis: Possible abnormalities in blood-brain barrier function. J Neurol Sci 1993;115:125-131.
31. Lisk DR, Grotta JC, Lamki LM et al. Should hypertension be treated after acute stroke? A randomized controlled trial using single proton emission computed tomography. Arch Neurol 1993;50:855-862.
32. Rapoport SI, Robinson PJ. Tight-junctional modification as the basis of osmotic opening of the blood-brain barrier. Ann NY Acad Sci USA1986;481:250-267.
33. Johansson B. Blood-brain barrier dysfunction in acute arterial hypertension after papaverine-induced vasodilatation. Acta Neurol Scand 1974;50:573-580.
34. Höllerhage H-G, Gaab MR, Zumkeller M, Walter GF. The influence of nimodipine on cerebral blood flow autoregulation and blood-brain barrier. J Neurosurg 1988;69:919-922.
35. Mayhan WG, Faraci FM, Heistad DD. Effects of vasodilatation and acidosis on the blood-brain barrier. Microvascular Res 1988;35:179-192.
36. Rybak LP. Ototoxicity of loop diuretics. Otolaryngol Clin North Am 1993;26:829-844.
37. Barthelmebs M, Stephan D, Fontaine C et al. Vascular effects of loop diuretics: an in vivo and in vitro study in the rat. Naunyn Schmiedebergs Arch Pharmacol 1994;349:209-216.
38. Freedman LS, Graubard BI, Schatzkin A. Statistical validation of intermediate endpoints for chronic diseases. Stat Med 1992;11:167-178.
39. Skoog I, Lernfelt B, Landahl S et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996;347:1141-1145.
40. Prince MJ, Bird AS, Blizard RA, Mann AH. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's treatment trial of hypertension in older adults. Br Med J 1996;312:801-805.
41. Skinner MH, Futterman A, Morrissette D et al. Atenolol compared with nifedipine: effect on cognitive function and mood in elderly hypertensive patients. Ann Intern Med 1992;116:615-623.